Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 07/31/13
Due: 07/31/14
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effect of Aerobic Training in Moderate or Severe Asthmatic Patients | NCT02033122 | Instituto de Investigação em Imunologia | user2@example.com | None | 2012-07-31 | 2014-12-31 | 2015-12-31 | - | - | 2025-07-14 |
| mRNA Expression as a Biomarker of Omalizumab Response | NCT01584687 | Instituto de Investigação em Imunologia | user2@example.com | None | 2012-06-30 | 2012-12-31 | 2013-12-31 | - | - | 2025-07-14 |
| Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) | NCT01584115 | Instituto de Investigação em Imunologia | user2@example.com | None | 2012-07-31 | 2013-07-31 | 2014-07-31 | - | - | 2025-07-14 |